Clinical Trial Update: Phase 1 Renal Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating Methoxyethyl Etomidate Hydrochloride in renal insufficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Insufficiency

Drugs mentioned

• Methoxyethyl Etomidate Hydrochloride (methoxyethyl etomidate hydrochloride)

Snippet

Sponsor: Ahon Pharmaceutical Co., Ltd. | Conditions: Renal Insufficiency | Phase 1 | Status: COMPLETED